210 related articles for article (PubMed ID: 34452691)
21. Summary of the development the US Environmental Protection Agency's Medaka Extended One Generation Reproduction Test (MEOGRT) using data from 9 multigenerational medaka tests.
Flynn K; Lothenbach D; Whiteman F; Hammermeister D; Touart LW; Swintek J; Tatarazako N; Onishi Y; Iguchi T; Johnson R
Environ Toxicol Chem; 2017 Dec; 36(12):3387-3403. PubMed ID: 28857258
[TBL] [Abstract][Full Text] [Related]
22. Assessing utility of thyroid in vitro screening assays through comparisons to observed impacts in vivo.
Eytcheson SA; Olker JH; Friedman KP; Hornung MW; Degitz SJ
Regul Toxicol Pharmacol; 2023 Oct; 144():105491. PubMed ID: 37666444
[TBL] [Abstract][Full Text] [Related]
23. A novel framework for interpretation of data from the fish short-term reproduction assay (FSTRA) for the detection of endocrine-disrupting chemicals.
Ankley GT; Jensen KM
Environ Toxicol Chem; 2014 Nov; 33(11):2529-40. PubMed ID: 25098918
[TBL] [Abstract][Full Text] [Related]
24. Identification of non-validated endocrine disrupting chemical characterization methods by screening of the literature using artificial intelligence and by database exploration.
Zgheib E; Kim MJ; Jornod F; Bernal K; Tomkiewicz C; Bortoli S; Coumoul X; Barouki R; De Jesus K; Grignard E; Hubert P; Katsanou ES; Busquet F; Audouze K
Environ Int; 2021 Sep; 154():106574. PubMed ID: 33895441
[TBL] [Abstract][Full Text] [Related]
25. Environmental effect assessment for sexual endocrine-disrupting chemicals: Fish testing strategy.
Knacker T; Boettcher M; Frische T; Rufli H; Stolzenberg HC; Teigeler M; Zok S; Braunbeck T; Schäfers C
Integr Environ Assess Manag; 2010 Oct; 6(4):653-62. PubMed ID: 20872646
[TBL] [Abstract][Full Text] [Related]
26. Introduction to "screening for endocrine activity-experiences with the US EPA's endocrine disruptor screening program and future considerations".
Marty S
Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):1-2. PubMed ID: 24510782
[No Abstract] [Full Text] [Related]
27. Failure to Launch: The Endocrine Disruptor Screening Program at the U.S. Environmental Protection Agency.
Maffini MV; Vandenberg LN
Front Toxicol; 2022; 4():908439. PubMed ID: 35707496
[TBL] [Abstract][Full Text] [Related]
28. Endocrine disrupting chemicals: strategies to protect present and future generations.
Vandenberg LN
Expert Rev Endocrinol Metab; 2021 May; 16(3):135-146. PubMed ID: 33973826
[No Abstract] [Full Text] [Related]
29. Emerging concepts and opportunities for endocrine disruptor screening of the non-EATS modalities.
Martyniuk CJ; Martínez R; Navarro-Martín L; Kamstra JH; Schwendt A; Reynaud S; Chalifour L
Environ Res; 2022 Mar; 204(Pt A):111904. PubMed ID: 34418449
[TBL] [Abstract][Full Text] [Related]
30. On selecting a minimal set of in vitro assays to reliably determine estrogen agonist activity.
Judson RS; Houck KA; Watt ED; Thomas RS
Regul Toxicol Pharmacol; 2017 Dec; 91():39-49. PubMed ID: 28993267
[TBL] [Abstract][Full Text] [Related]
31. Review and analysis of the potential for glyphosate to interact with the estrogen, androgen and thyroid pathways.
Levine SL; Webb EG; Saltmiras DA
Pest Manag Sci; 2020 Sep; 76(9):2886-2906. PubMed ID: 32608552
[TBL] [Abstract][Full Text] [Related]
32. Towards regulation of Endocrine Disrupting chemicals (EDCs) in water resources using bioassays - A guide to developing a testing strategy.
Robitaille J; Denslow ND; Escher BI; Kurita-Oyamada HG; Marlatt V; Martyniuk CJ; Navarro-Martín L; Prosser R; Sanderson T; Yargeau V; Langlois VS
Environ Res; 2022 Apr; 205():112483. PubMed ID: 34863984
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Tier I screening approaches for detecting endocrine-active compounds (EACs).
O'Connor JC; Cook JC; Marty MS; Davis LG; Kaplan AM; Carney EW
Crit Rev Toxicol; 2002; 32(6):521-49. PubMed ID: 12487364
[TBL] [Abstract][Full Text] [Related]
34. Analysis of EPA's endocrine screening battery and recommendations for further review.
Schapaugh AW; McFadden LG; Zorrilla LM; Geter DR; Stuchal LD; Sunger N; Borgert CJ
Regul Toxicol Pharmacol; 2015 Aug; 72(3):552-61. PubMed ID: 26044367
[TBL] [Abstract][Full Text] [Related]
35. Endocrine disrupters--testing strategies to assess human hazard.
Baker VA
Toxicol In Vitro; 2001; 15(4-5):413-9. PubMed ID: 11566572
[TBL] [Abstract][Full Text] [Related]
36. Tributyltin: Advancing the Science on Assessing Endocrine Disruption with an Unconventional Endocrine-Disrupting Compound.
Lagadic L; Katsiadaki I; Biever R; Guiney PD; Karouna-Renier N; Schwarz T; Meador JP
Rev Environ Contam Toxicol; 2018; 245():65-127. PubMed ID: 29119384
[TBL] [Abstract][Full Text] [Related]
37. FIFRA Subdivision F testing Guidelines: are these tests adequate to detect potential hormonal activity for crop protection chemicals? Federal Insecticide, Fungicide, and Rodenticide Act.
Stevens JT; Tobia A; Lamb JC; Tellone C; O'Neal F
J Toxicol Environ Health; 1997 Apr; 50(5):415-31. PubMed ID: 9140462
[TBL] [Abstract][Full Text] [Related]
38. Selecting appropriate animal models and experimental designs for endocrine disruptor research and testing studies.
Stokes WS
ILAR J; 2004; 45(4):387-93. PubMed ID: 15454677
[TBL] [Abstract][Full Text] [Related]
39. CoMPARA: Collaborative Modeling Project for Androgen Receptor Activity.
Mansouri K; Kleinstreuer N; Abdelaziz AM; Alberga D; Alves VM; Andersson PL; Andrade CH; Bai F; Balabin I; Ballabio D; Benfenati E; Bhhatarai B; Boyer S; Chen J; Consonni V; Farag S; Fourches D; García-Sosa AT; Gramatica P; Grisoni F; Grulke CM; Hong H; Horvath D; Hu X; Huang R; Jeliazkova N; Li J; Li X; Liu H; Manganelli S; Mangiatordi GF; Maran U; Marcou G; Martin T; Muratov E; Nguyen DT; Nicolotti O; Nikolov NG; Norinder U; Papa E; Petitjean M; Piir G; Pogodin P; Poroikov V; Qiao X; Richard AM; Roncaglioni A; Ruiz P; Rupakheti C; Sakkiah S; Sangion A; Schramm KW; Selvaraj C; Shah I; Sild S; Sun L; Taboureau O; Tang Y; Tetko IV; Todeschini R; Tong W; Trisciuzzi D; Tropsha A; Van Den Driessche G; Varnek A; Wang Z; Wedebye EB; Williams AJ; Xie H; Zakharov AV; Zheng Z; Judson RS
Environ Health Perspect; 2020 Feb; 128(2):27002. PubMed ID: 32074470
[TBL] [Abstract][Full Text] [Related]
40. Chemistry domain of applicability evaluation against existing estrogen receptor high-throughput assay-based activity models.
Nelms MD; Antonijevic T; Ring C; Harris DL; Bever RJ; Lynn SG; Williams D; Chappell G; Boyles R; Borghoff S; Edwards SW; Markey K
Front Toxicol; 2024; 6():1346767. PubMed ID: 38694816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
